Brazil moves to standardise device nomenclature and labelling
This article was originally published in Clinica
Executive Summary
Brazil is considering using a translation of the Global Medical Device Nomenclature (GMDN) as the basis of its "common denomination of healthcare products" (DCB-PS). The plans are subject to two brief consultations, currently under way: one relates to the list of terms themselves; the other, to technical considerations, such as: the forms to apply for the inclusion, alteration or removal of terms from the DCB-PS list, and labelling requirements. The proposals (published officially in the May 15 Di�rio Oficial da União) can be accessed via the Anvisa website (www.anvisa.gov.br); the consultations are scheduled to end on June 15.
You may also be interested in...
Teva Slapped With €60m Fine Over Unlawful EU Provigil Delay
Teva received a “package of commercial side-deals” for agreeing to halt generic competition to Cephalon’s Provigil (modafinil) throughout the EU, which it “would not have achieved without committing to staying out of the market,” according to findings by the European Commission.
ASTM Developing Standard To Tackle Dried Blood On Steel Devices
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executives On The Move: CEOs Named At Elevation Oncology, PainReform Ltd
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
Need a specific report? 1000+ reports available
Buy Reports